Professor Rotili is Full Professor of Pharmaceutical Chemistry at Roma Tre University. After graduating in Chemistry and Pharmaceutical Technologies and obtaining a PhD in Pharmaceutical Sciences at Sapienza University, he was a long-time Research Associate at the University of Oxford. Since returning to Italy in 2011, he has been involved in the development of epigenetic target modulators as anticancer and anti-infective agents, the development of radiopharmaceuticals for theranostic applications, and the application of native mass spectrometry to the study of protein-protein and protein-ligand interactions.